1. Early Mucosal Healing Predicts Favorable Outcomes in Patients With Moderate to Severe Ulcerative Colitis Treated With Golimumab: Data From the Real-life BE-SMART Cohort. Issue 1 (1st January 2019) Authors: Bossuyt, Peter; Baert, Filip; D'Heygere, Francois; Nakad, Antoine; Reenaers, Catherine; Fontaine, Fernand; Franchimont, Denis; Dewit, Olivier; Van Hootegem, Philippe; Vanden Branden, Stijn; Lambrecht, Guy; Ferrante, Marc; Hindryckx, Pieter; Macken, Elisabeth; Caenepeel, Philip; Vijverman, Anne; S... Journal: Inflammatory bowel diseases Issue: Volume 25:Issue 1(2019) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Effect of vedolizumab dose intensification on serum drug concentrations and regain of response in inflammatory bowel disease patients with secondary loss of response. Issue 2 (28th February 2021) Authors: Outtier, An; Wauters, Lucas; Rahier, Jean‐Francois; Bossuyt, Peter; Colard, Arnaud; Franchimont, Denis; Lambrecht, Guy; Macken, Elisabeth; Van Moerkercke, Wouter; Baert, Filip; Humblet, Evelien; Van Hootegem, Philippe; Gils, Ann; Ferrante, Marc; Vermeire, Séverine Journal: GastroHep Issue: Volume 3:Issue 2(2021) Page Start: 63 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Efficacy of vedolizumab for induction of clinical response and remission in patients with moderate to severe inflammatory bowel disease who failed at least two TNF antagonists. Issue 3 (1st April 2018) Authors: De Vos, Martine; Dhooghe, Barbara; Vermeire, Severine; Louis, Edouard; Mana, Fazia; Elewaut, Ann; Bossuyt, Peter; Baert, Filip; Reenaers, Catherine; Van Gossum, Marc; Macken, Elisabeth; Ferrante, Marc; Hindryckx, Pieter; Dewit, Olivier; Holvoet, Tom; Franchimont, Denis Journal: United European Gastroenterology journal Issue: Volume 6:Issue 3(2018) Page Start: 439 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Efficacy of vedolizumab for induction of clinical response and remission in patients with moderate to severe inflammatory bowel disease who failed at least two TNF antagonists. Issue 3 (April 2018) Authors: De Vos, Martine; Dhooghe, Barbara; Vermeire, Severine; Louis, Edouard; Mana, Fazia; Elewaut, Ann; Bossuyt, Peter; Baert, Filip; Reenaers, Catherine; Van Gossum, Marc; Macken, Elisabeth; Ferrante, Marc; Hindryckx, Pieter; Dewit, Olivier; Holvoet, Tom; Franchimont, Denis Journal: United European Gastroenterology journal Issue: Volume 6:Issue 3(2018) Page Start: 439 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. In-Depth Study of Transmembrane Mucins in Association with Intestinal Barrier Dysfunction During the Course of T Cell Transfer and DSS-Induced Colitis. (31st January 2020) Authors: Breugelmans, Tom; Van Spaendonk, Hanne; De Man, Joris G; De Schepper, Heiko U; Jauregui-Amezaga, Aranzazu; Macken, Elisabeth; Lindén, Sara K; Pintelon, Isabel; Timmermans, Jean-Pierre; De Winter, Benedicte Y; Smet, Annemieke Journal: Journal of Crohn's and colitis Issue: Volume 14:Number 7(2020) Page Start: 974 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Long-term Clinical Effectiveness of Ustekinumab in Patients with Crohn's Disease Who Failed Biologic Therapies: A National Cohort Study. (16th April 2019) Authors: Liefferinckx, Claire; Verstockt, Bram; Gils, Ann; Noman, Maja; Van Kemseke, Catherine; Macken, Elisabeth; De Vos, Martine; Van Moerkercke, Wouter; Rahier, Jean-Francois; Bossuyt, Peter; Dutré, Joris; Humblet, Evelien; Staessen, Dirk; Peeters, Harald; Van Hootegem, Philippe; Louis, Edouard; Franch... Journal: Journal of Crohn's and colitis Issue: Volume 13:Number 11(2019) Page Start: 1401 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Outcome of Pregnancies in Female Patients With Inflammatory Bowel Diseases Treated With Vedolizumab. (3rd October 2018) Authors: Moens, Annick; van Hoeve, Karen; Humblet, Evelien; Rahier, Jean-François; Bossuyt, Peter; Dewit, Sophie; Franchimont, Denis; Macken, Elisabeth; Nijs, Jochen; Posen, Annelies; Strubbe, Beatrijs; Van Hootegem, Anneleen; Van Moerkercke, Wouter; Vermeire, Séverine; Ferrante, Marc Journal: Journal of Crohn's and colitis Issue: Volume 13:Number 1(2019) Page Start: 12 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Pregnancy outcomes in inflammatory bowel disease patients treated with vedolizumab, anti‐TNF or conventional therapy: results of the European CONCEIVE study. Issue 1 (6th November 2019) Authors: Moens, Annick; van der Woude, C. Janneke; Julsgaard, Mette; Humblet, Evelien; Sheridan, Juliette; Baumgart, Daniel C.; Gilletta De Saint‐Joseph, Cyrielle; Nancey, Stéphane; Rahier, Jean‐François; Bossuyt, Peter; Cremer, Anneline; Dewit, Sophie; Eriksson, Carl; Hoentjen, Frank; Krause, Thomas; Lou... Journal: Alimentary pharmacology & therapeutics Issue: Volume 51:Issue 1(2020) Page Start: 129 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Role of integrin expression in the prediction of response to vedolizumab: A prospective real‐life multicentre cohort study. Issue 4 (5th April 2022) Authors: De Galan, Cara; Gonzales, Gerard Bryan; Van Welden, Sophie; Tavernier, Simon Jan; Lobaton, Triana; Van Moerkercke, Wouter; Strubbe, Beatrijs; Peeters, Harald; Macken, Elisabeth; De Vos, Martine; Laukens, Debby; Hindryckx, Pieter Journal: Clinical and translational medicine Issue: Volume 12:Issue 4(2022) Page Start: n/a Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗